2. Method
This study was a single-center double-blinded randomized controlled clinical trial. Prior to participation in this study, all subjects were asked for written informed consent for participating in the trial. The trial was registered prior to patient enrollment with the Chinese Clinical Trial Registry (ChiCTR2100054038, Principal investigator: Ting Yang, 